AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: The activation of the PI3K/AKT/mammalian target of rapamycin (mTOR) signalling pathway is another major BCR::ABL1-driven pathway that promotes cell growth and cell proliferation in CML cells (Figure 3) [67].